The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 201–300 of 1,000
Marcinkeviciene, J. A., Magliozzo, R. S., & Blanchard, J. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22290 · Cited by 112
Mdluli, K., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S., Stover, C. K., & Barry, C. E. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1085 · Cited by 112
Drobniewski, F. A., Cooke, M., Jordan, J., Casali, N., Mugwagwa, T., Broda, A., Townsend, C. L., Sivaramakrishnan, A., Green, N., Jit, M., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19340 · Cited by 121
Dover, L. G., Corsino, P. E., Daniels, I. R., Cocklin, S., Tatituri, V., Besra, G. S., & Fütterer, K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.003 · Cited by 111
Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. D. M., Telles, M. A. S., Kritski, A. L., Morlock, G. P., Cooksey, R. C., Zaha, A., & Rossetti, M. L. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4471-4474.2003 · Cited by 133
Tuberculosis Symposium: Emerging Problems and Promise
Ellner, J. J., Hinman, A. R., Dooley, S. W., Fischl, M. A., Sepkowitz, K. A., Goldberger, M. J., Shinnick, T. M., Iseman, M. D., & Jacobs, W. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.537 · Cited by 119
Stoffels, K., Mathys, V., Fauville‐Dufaux, M., Wintjens, R. T., & Bifani, P. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05385-11 · Cited by 110
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis
Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D. J., & Amaral, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2804-2810.2002 · Cited by 110
Drobniewski, F. A., & Wilson, S. M. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-3-189 · Cited by 123
Tetracycline resistance determinants in Mycobacterium and Streptomyces species
Pang, Y., Brown, B. A., Steingrube, V. A., Wallace, R. J., & Roberts, M. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1408 · Cited by 108
Ahmad, Z., Klinkenberg, L. G., Pinn, M. L., Fraig, M., Peloquin, C. A., Bishai, W. R., Nuermberger, E. L., Grosset, J. H. E., & Karakousis, P. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/605605 · Cited by 108
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
Torres, J., Paul, L. V., Rodwell, T. C., Victor, T. C., Amallraja, A., Elghraoui, A., Goodmanson, A. P., Ramirez-Busby, S. M., Chawla, A., Zadorozhny, V., et al. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.42 · Cited by 107
Synthetic Retinoids: Recent Developments Concerning Structure and Clinical Utility
Kagechika, H., & Shudo, K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0581821 · Cited by 106
Honoré, N., Bergh, S., Chanteau, S., Doucet‐Populaire, F., Eiglmeir, K., Garnier, T., Georges, C., Launois, P., Limpaiboon, T., Newton, S. M. C., et al. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01112.x · Cited by 117
Self-citationSchraufnagel, D. E. (2004) · Springer eBooks · doi:10.1007/978-3-642-18937-1_44 · Cited by 107
Hit Generation in TB Drug Discovery: From Genome to Granuloma
Yuan, T., & Sampson, N. S. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00602 · Cited by 110
RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities
Barczak, A. K., Gomez, J. E., Kaufmann-Malaga, B., Hinson, E. R., Cosimi, L. A., Borowsky, M. L., Onderdonk, A. B., Stanley, S. A., Kaur, D., Bryant, K. F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119540109 · Cited by 105
Jiang, X., Zhang, W., Zhang, Y., Gao, F., Lu, C., Zhang, X., & Wang, H. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0772 · Cited by 104
Self-citationBuvaneswari, M., Santhakumari, R., Usha, C., Jayasree, R., & Sagadevan, S. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130856 · Cited by 104
Zahrt, T. C., & Deretic, V. P. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602753625924 · Cited by 118
Menendez, C., Gau, S., Lherbet, C., Rodriguez, F., Inard, C., Pasca, M. R., & Baltas, M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.013 · Cited by 105
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico
Ramaswamy, S. V., Dou, S.-J., Rendón, A., Yang, Z., Cave, M. D., & Graviss, E. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05343-0 · Cited by 116
Sandy, J., Mushtaq, A., Kawamura, A., Sinclair, J., Sim, E., & Noble, M. E. M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00141-9 · Cited by 103
Levin, M. E., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01572.x · Cited by 126
Drug sensitivity and environmental adaptation of myocobacterial cell wall components
Barry, C. E., & Mdluli, K. E. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10031-7 · Cited by 102
Reactive species and pathogen antioxidant networks during phagocytosis
Piacenza, L., Trujillo, M., & Radí, R. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181886 · Cited by 109
Cardoso, R. F., Cooksey, R. C., Morlock, G. P., Barco, P., Cecon, L., Forestiero, F., Leite, C. Q. F., Sato, D. N., Shikama, M. D. L. M., Mamizuka, E. M., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3373-3381.2004 · Cited by 102
Guimarães, B. G., Souchon, H., Honoré, N., Saint-Joanis, B., Brosch, R., Shepard, W., Cole, S. T., & Alzari, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503076200 · Cited by 99
Self-citationAnderson, M. D., Chen, Z., & Klessig, D. F. (1998) · Phytochemistry · doi:10.1016/s0031-9422(97)00726-7 · Cited by 99
Timm, J., Perilli, M., Duez, C., Trias, J., Orefici, G., Fattorini, L., Amicosante, G., Oratore, A., Joris, B., Frère, J.-M., et al. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01037.x · Cited by 110
Clinical value of whole-genome sequencing of Mycobacterium tuberculosis
Takiff, H. E., & Feo, O. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00071-7 · Cited by 106
Ahmad, S., & Mokaddas, E. M. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.09.001 · Cited by 105
Brossier, F., Véziris, N., Truffot-Pernot, C., Jarlier, V., & Sougakoff, W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01030-10 · Cited by 98
Bergval, I. L., Schuitema, A. R. J., Klatser, P. R., & Anthony, R. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp237 · Cited by 92
Drug resistance mechanisms and novel drug targets for tuberculosis therapy
Islam, M. M., Hameed, H. M. A., Mugweru, J., Chhotaray, C., Wang, C., Tan, Y., Liu, J., Li, X., Tan, S., Ojima, I., et al. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.10.002 · Cited by 102
Mycobacterium tuberculosis : Pathogenesis and therapeutic targets
Yang, J., Zhang, L., Qiao, W., & Luo, Y. (2023) · MedComm · doi:10.1002/mco2.353 · Cited by 109
The uraA locus and homologous recombination in Mycobacterium bovis BCG
Aldovini, A., Husson, R. N., & Young, R. A. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7282-7289.1993 · Cited by 104
The thiol‐based redox networks of pathogens: Unexploited targets in the search for new drugs
Jaeger, T., & Flohé, L. (2006) · BioFactors · doi:10.1002/biof.5520270110 · Cited by 104
Antibiotic resistance in the absence of selective pressure
Gillespie, S. H. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00340-x · Cited by 94
Bloom, B. R. (1992) · Nature · doi:10.1038/358538b0 · Cited by 94
Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds
Pan, P., & Tonge, P. J. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799984535 · Cited by 93
PROSPECTS FOR NEW INTERVENTIONS IN THE TREATMENT AND PREVENTION OF MYCOBACTERIAL DISEASE
Young, D. B., & Duncan, K. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.003233 · Cited by 93
Self-citationAndo, H., Kondo, Y., Suetake, T., Toyota, E., Kato, S., Mori, T., & Kirikae, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01691-09 · Cited by 91
Antibiotic preparations contain DNA: a source of drug resistance genes?
Webb, V., & DAVIES, J. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2379 · Cited by 103
Timmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3006-3009.2004 · Cited by 90
Quémard, A., Dessen, A., Sugantino, M., Jacobs, W. R., Sacchettini, J. C., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja950998b · Cited by 90
Feuerriegel, S., Oberhauser, B., George, A., Dafae, F. M., Richter, E., Rüsch–Gerdes, S., & Niemann, S. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-90 · Cited by 89
Evolution of structure and function of Class I peroxidases
Zámocký, M., Furtmüller, P. G., & Obinger, C. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.03.024 · Cited by 89
Wei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Laqueyrerie, A., Militzer, P., Romain, F., Eiglmeier, K., Cole, S. T., & Marchal, G. (1995) · Infection and Immunity · doi:10.1128/iai.63.10.4003-4010.1995 · Cited by 98
Self-citationRedox Biology of Tuberculosis Pathogenesis
Trivedi, A., Singh, N., Bhat, S. A., Gupta, P., & Kumar, A. (2012) · Advances in Microbial Physiology · doi:10.1016/b978-0-12-398264-3.00004-8 · Cited by 88
Nayak, N., Ramprasad, J., & Dalimba, U. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.057 · Cited by 88
Laurenzo, D., & Mousa, S. A. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.04.008 · Cited by 88
Catalase-peroxidases (KatG) Exhibit NADH Oxidase Activity
Singh, R., Wiseman, B., Deemagarn, T., Donald, L. J., Duckworth, H. W., Carpena, X., Fita, I., & Loewen, P. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406374200 · Cited by 88
Engström, A., Morcillo, N., Imperiale, B. R., Hoffner, S. E., & Juréen, P. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06664-11 · Cited by 92
Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., & Meunier, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2137-2144.2002 · Cited by 86
Tuberculosis and acquired immunodeficiency syndrome: A historical perspective on recent developments
Haas, D. W., & Prez, R. M. D. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90171-6 · Cited by 99
Arnold, C. E., Westland, L., Mowat, G., Underwood, A. P., Magee, J., & Gharbia, S. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01034.x · Cited by 85
Drug-resistance in Mycobacterium tuberculosis : where we stand
Mabhula, A., & Singh, V. (2019) · MedChemComm · doi:10.1039/c9md00057g · Cited by 96
Pagán-Ramos, E., Song, J., McFalone, M., Mudd, M. H., & Deretic, V. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4856-4864.1998 · Cited by 82
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases
Metcalfe, C. L., Macdonald, I. K., Murphy, E. J., Brown, K. A., Raven, E. L., & Moody, P. C. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707412200 · Cited by 83
Catalases Are NAD(P)H-Dependent Tellurite Reductases
Calderón, I. L., Arenas, F., Pérez, J. M., Fuentes, D. E., Araya, M. A., Saavedra, C. P., Tantaleán, J. C., Pichuantes, S. E., Youderian, P. A., & Vásquez, C. C. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000070 · Cited by 92
Mycobacterium tuberculosisKatG Is a Peroxynitritase
Wengenack, N. L., Jensen, M. P., Rusnak, F. M., & Stern, M. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0358 · Cited by 100
Magliozzo, R. S., & Marcinkeviciene, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8867 · Cited by 82
Novel targets in M. tuberculosis: search for new drugs
Lamichhane, G. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.004 · Cited by 96
Plasticity of Mycobacterium tuberculosis NADH dehydrogenases and their role in virulence
Vilchèze, C., Weinrick, B. C., Leung, L. W., & Jacobs, W. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721545115 · Cited by 86
Proteome-wide Profiling of Isoniazid Targets in Mycobacterium tuberculosis
Argyrou, A., Jin, L., Siconolfi-Baez, L., Angeletti, R. H., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi061874m · Cited by 81
Amo, T., Atomi, H., & Imanaka, T. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.12.3305-3312.2002 · Cited by 81
Kremer, L., Dover, L. G., Morbidoni, H. R., Vilchèze, C., Maughan, W. N., Baulard, A. R., Tu, S., Honoré, N., Deretic, V. P., Sacchettini, J. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302435200 · Cited by 96
Parsons, L. M., Salfinger, M., Clobridge, A., Dormandy, J., Mirabello, L. J., Polletta, V. L., Saniç, A., Sinyavskiy, O., Larsen, S. C., Driscoll, J. R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2218-2225.2005 · Cited by 88
Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis
Emane, A. K. A., Guo, X., Takiff, H. E., & Liu, S. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102091 · Cited by 86
A silent mutation in mabA confers isoniazid resistance on M ycobacterium tuberculosis
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2013) · Molecular Microbiology · doi:10.1111/mmi.12476 · Cited by 91
Banerjee, A., Sugantino, M., Sacchettini, J. C., & Jacobs, W. R. (1998) · Microbiology · doi:10.1099/00221287-144-10-2697 · Cited by 96
Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors
Ende, C. W. A., Knudson, S. E., Liu, N., Childs, J., Sullivan, T. J., Boyne, M. E., Xu, H., Gegina, Y., Knudson, D. L., Johnson, F., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.038 · Cited by 79
Ta, P., Buchmeier, N., Newton, G. L., Rawat, M., & Fahey, R. C. (2011) · Journal of Bacteriology · doi:10.1128/jb.01402-10 · Cited by 78
Baker, L. V., Brown, T., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., & Drobniewski, F. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1455-1464.2005 · Cited by 86
Mycobacterium Tuberculosis: Drug Resistance and Future Perspectives
Riccardi, G., Pasca, M. R., & Buroni, S. (2009) · Future Microbiology · doi:10.2217/fmb.09.20 · Cited by 86
Nishida, C. R., & de Montellano, P. R. O. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.015 · Cited by 77
Rana, P., Ghouse, S. M., Akunuri, R., Madhavi, Y. V., Chopra, S., & Nanduri, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112757 · Cited by 76
Liu, L., Xu, Y., Shea, C., Fowler, J. S., Hooker, J. M., & Tonge, P. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901858n · Cited by 76
Jnawali, H. N., Hwang, S. C., Park, Y. K., Kim, H.-J., Lee, Y. S., Chung, G. T., Choe, K. H., & Ryoo, S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.035 · Cited by 79
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Barry, III, & Kendall Stover, C. (1999) · BioFactors · doi:10.1002/biof.5520100219 · Cited by 71
Freundlich, J. S., Wang, F., Tsai, H.-C., Kuo, M. R., Shieh, H.-M., Anderson, J. W., Nkrumah, L. J., Valderramos, J., Yu, M., Kumar, T. R. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701813200 · Cited by 76
Marttila, H., Soini, H., Huovinen, P., & Viljanen, M. K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2187 · Cited by 76
Epidemiology of Isoniazid Resistance Mutations and Their Effect on Tuberculosis Treatment Outcomes
Huyen, M. N. T., Cobelens, F. G. J., Buu, T. N., Lan, N. T. N., Dung, N. H., Kremer, K., Tiemersma, E. W., & van Soolingen, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00077-13 · Cited by 84
Liu, J., Shi, W., Zhang, S., Cassell, G., Maslov, D. A., Shur, K. V., Bekker, O. B., Даниленко, В. Н., Hao, X., & Zhang, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00216 · Cited by 75
Self-citationSchöneborn, H., Bulle, J. M. G., & von Kiedrowski, G. (2001) · ChemBioChem · doi:10.1002/1439-7633(20011203)2:12<915::aid-cbic915>3.0.co;2-m · Cited by 21
Takahashi, B., Ohta, K., Kawachi, E., Fukasawa, H., Hashimoto, Y., & Kagechika, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255320 · Cited by 73
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium
Mdluli, K. E., Swanson, J., Fischer, E. R., Lee, R. E., Jr., & Barry, C. E. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00774.x · Cited by 74
Whelen, A. C., Felmlee, T. A., Hunt, J. M., Williams, D. L., Roberts, G. D., Stockman, L., & Persing, D. H. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.556-561.1995 · Cited by 75
3 Persisting problems in tuberculosis
McKinney, J. D., Jacobs, W. R., & Bloom, B. R. (1998) · Biomedical research reports · doi:10.1016/s1874-5326(07)80027-5 · Cited by 82
Huang, W., Zhang, L., Sun, J., Sun, Y., Gong, L., Ge, S., Zheng, Y., Gao, W., & Wei, X. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c13501 · Cited by 73
Kibiki, G. S., Mulder, B., Dolmans, W. M. V., de Beer, J. L., Boeree, M. J., Sam, N., van Soolingen, D., Sola, C., & van der Zanden, A. G. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-51 · Cited by 73
Mycobacterium tuberculosis: drug-resistance mechanisms
Cole, S. T. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90621-1 · Cited by 73
Self-citationIsonicotinic Acid Hydrazide Conversion to Isonicotinyl-NAD by Catalase-peroxidases
Wiseman, B., Carpena, X., Feliz, M., Donald, L. J., Pons, M., Fita, I., & Loewen, P. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139428 · Cited by 72
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment
Gomez, J. E., Kaufmann-Malaga, B., Wivagg, C. N., Kim, P. B., Silvis, M. R., Renedo, N., Ioerger, T. R., Ahmad, R., Livny, J., Fishbein, S. R. S., et al. (2017) · eLife · doi:10.7554/elife.20420 · Cited by 79
Multi-Drug-Resistant Tuberculosis
Davies, P. D. O. (2004) · Springer eBooks · doi:10.1007/978-3-642-18937-1_46 · Cited by 74
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.